International Journal of Health Policy and Management

International Journal of Health Policy and Management

Effects of Activity-Based Hospital Payments in Israel: A Qualitative Evaluation Focusing on the Perspectives of Hospital Managers and Physicians

Document Type : Original Article

Authors
Ruth Waitzberg 1, 2, 3
Wilm Quentin 3, 4
Elad Daniels 1
Yael Paldi 5
Reinhard Busse 3, 4
Dan Greenberg 2
1 The Smokler Center for Health Policy Research, Myers-JDC-Brookdale Institute, Jerusalem, Israel
2 Department of Health Systems Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
3 Department of Health Care Management, Faculty of Economics & Management, Technical University Berlin, Berlin, Germany
4 European Observatory on Health Systems and Policies, Brussels, Belgium
5 Maccabi Healthcare Services, Tel Aviv-Yafo, Israel
10.34172/ijhpm.2020.51
Abstract
Background
Since 2010, Israel has expanded the adoption of procedure-related group (PRG) based payments for hospitals. While there is a rich quantitative literature that assesses the effects of payment reforms on efficiency or quality of care, very few qualitative studies have focused on the impacts of diagnosis-related group (DRG)-like payments on hospitals from the perspective of hospital workers as change agents.

 
Methods
We used a qualitative, thematic analysis based on 33 semi-structured in-depth interviews with chief executive officers (CEOs), chief financial officers (CFOs), ward directors and physicians conducted in five public hospitals in Israel, sampled by maximum variation according to hospital characteristics.

 
Results
Interviewees reported that the payment reform led to organizational changes such as increased transparency and enhanced supervision. Interviewees also reported several actions in response to the economic incentives of PRGbased payment. These included (1) shifting activities to afterhours and using operating rooms (ORs) more efficiently to enable increased surgical volumes; (2) reducing costs by shortening lengths of stay and increasing cost-consciousness in procurement; and (3) increasing revenues by improving coding and selecting procedures. Moderating factors reduced the effects of the reform. For example, organizational factors such as the public nature of hospitals or the (un)availability of healthcare resources did not always allow hospitals to increase the number of cases treated. Also, conflicting incentives such as multiple payment mechanisms or underpricing of procedures blurred the incentives of the reform. Finally, managers and physicians have many other considerations that outweigh the economic ones.

 
Conclusion
PRG payments affected the organizational dynamics of hospitals and changed decision-making about admission and treatment policies. However, such effects were moderated by many other factors that should be considered when shaping and analyzing hospital payment reforms.

Highlights

Supplementary File 1 (Download)

Keywords
Health Policy Evaluation
Hospital Payment Reform
Diagnosis-Related Group
Israel
  1. Srivastava D, Müller M, Hewlett E. Better Ways to Pay for Health Care. Paris: OECD; 2016. doi:10.1787/9789264258211-en
  2. Ellis RP, McGuire TG. Hospital response to prospective payment: moral hazard, selection, and practice-style effects. J Health Econ. 1996;15(3):257-277. doi:10.1016/0167-6296(96)00002-1
  3. Geissler A, Quentin W, Scheller-Kreinsen D, Busse R. Introduction to DRGs in Europe: common objectives across different hospital systems. In: Busse R, ed. Diagnosis-Related Groups in Europe: Moving Towards Transparency, Efficiency, and Quality in Hospitals. Maidenhead: Open University Press McGraw-Hill Education; 2011:9-21.
  4. Brammli-Greenberg S, Waitzberg R, Perman V, Gamzu R. Why and how did Israel adopt activity-based hospital payment? The procedure-related group incremental reform. Health Policy. 2016;120(10):1171-1176. doi:10.1016/j.healthpol.2016.08.008
  5. Rosen B, Waitzberg R, Merkur S. Israel: health system review. Health Syst Transit. 2015;17(6):1-212.
  6. OECD. Hospital beds. OECD Data; 2017. https://data.oecd.org/healtheqt/hospital-beds.htm.  Accessed March 9, 2017.
  7. OECD. Frequently asked question, OECD Health statistics, 2017. http://www.oecd.org/health/health-statistics.htm.   Accessed March 9, 2017.
  8. Ministry of Health. Financial Report of the medical centers for years 2016–2017 [Hebrew].  2019: Available at: https://www.health.gov.il/publicationsfiles/financial-analysis-2016-2017-accessible.pdf.   Accessed March 9, 2017.
  9. Waitzberg R, Quentin W, Daniels E, et al. The 2010 expansion of activity-based hospital payment in Israel: an evaluation of effects at the ward level. BMC Health Serv Res. 2019;19(1):292. doi:10.1186/s12913-019-4083-4
  10. Palmer KS, Agoritsas T, Martin D, et al. Activity-based funding of hospitals and its impact on mortality, readmission, discharge destination, severity of illness, and volume of care: a systematic review and meta-analysis. PLoS One. 2014;9(10):e109975. doi:10.1371/journal.pone.0109975
  11. Cots F, Chiarello P, Salvador X, Castells X, Quentin W. DRG-based hospital payment: Intended and unintended consequences. In: Busse R, ed. Diagnosis-Related Groups in Europe: Moving Towards Transparency, Efficiency, and Quality in Hospitals. Maidenhead: Open University Press McGraw-Hill Education; 2011.
  12. Moreno-Serra R, Wagstaff A. System-wide impacts of hospital payment reforms: evidence from Central and Eastern Europe and Central Asia. J Health Econ. 2010;29(4):585-602. doi:10.1016/j.jhealeco.2010.05.007
  13. Cavalieri M, Gitto L, Guccio C. Reimbursement systems and quality of hospital care: an empirical analysis for Italy. Health Policy. 2013;111(3):273-289. doi:10.1016/j.healthpol.2013.05.014
  14. Or Z. Implementation of DRG Payment in France: issues and recent developments. Health Policy. 2014;117(2):146-150. doi:10.1016/j.healthpol.2014.05.006
  15. Shmueli A, Intrator O, Israeli A. The effects of introducing prospective payments to general hospitals on length of stay, quality of care, and hospitals’ income: the early experience of Israel. Soc Sci Med. 2002;55(6):981-989. doi:10.1016/s0277-9536(01)00233-7
  16. Baxter PE, Hewko SJ, Pfaff KA, et al. Leaders’ experiences and perceptions implementing activity-based funding and pay-for-performance hospital funding models: a systematic review. Health Policy. 2015;119(8):1096-1110. doi:10.1016/j.healthpol.2015.05.003
  17. Finkler SA, Ward DM. The case for the use of evidence-based management research for the control of hospital costs. Health Care Manage Rev. 2003;28(4):348-365. doi:10.1097/00004010-200310000-00007
  18. Sussex J, Farrar S. Activity-based funding for National Health Service hospitals in England: managers’ experience and expectations. Eur J Health Econ. 2009;10(2):197-206. doi:10.1007/s10198-008-0119-0
  19. Palmer KS, Brown AD, Evans JM, et al. Standardising costs or standardising care? qualitative evaluation of the implementation and impact of a hospital funding reform in Ontario, Canada. Health Res Policy Syst. 2018;16(1):74. doi:10.1186/s12961-018-0353-6
  20. Baxter P, Cleghorn L, Alvarado K, et al. Quality-based procedures in Ontario: exploring health-care leaders’ responses. J Nurs Manag. 2016;24(1):50-58. doi:10.1111/jonm.12271
  21. Fässler M, Wild V, Clarinval C, Tschopp A, Faehnrich JA, Biller-Andorno N. Impact of the DRG-based reimbursement system on patient care and professional practise: perspectives of Swiss hospital physicians. Swiss Med Wkly. 2015;145:w14080. doi:10.4414/smw.2015.14080
  22. Fourie C, Biller-Andorno N, Wild V. Systematically evaluating the impact of diagnosis-related groups (DRGs) on health care delivery: a matrix of ethical implications. Health Policy. 2014;115(2-3):157-164. doi:10.1016/j.healthpol.2013.11.014
  23. Wehkamp KH, Naegler H. The commercialization of patient-related decision making in hospitals. Dtsch Arztebl Int. 2017;114(47):797-804. doi:10.3238/arztebl.2017.0797
  24. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77-101. doi:10.1191/1478088706qp063oa
  25. Braun V, Clarke V. What can “thematic analysis” offer health and wellbeing researchers? Int J Qual Stud Health Well-being. 2014;9:26152. doi:10.3402/qhw.v9.26152
  26. Mathauer I, Wittenbecher F. Hospital payment systems based on diagnosis-related groups: experiences in low- and middle-income countries. Bull World Health Organ. 2013;91(10):746-756A. doi:10.2471/blt.12.115931
  27. Busse R, Geissler A, Aaviksoo A, et al. Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals? BMJ. 2013;346:f3197. doi:10.1136/bmj.f3197
  28. Fetter RB. Diagnosis related groups: understanding hospital performance. Interfaces. 1991;21(1):6-26.
  29. Fetter RB, Shin Y, Freeman JL, Averill RF, Thompson JD. Case mix definition by diagnosis-related groups. Med Care. 1980;18(2 Suppl):iii, 1-53.
  30. Parkinson B, Meacock R, Sutton M. How do hospitals respond to price changes in emergency departments? Health Econ. 2019;28(7):830-842.  doi:10.1002/hec.3890
  31. Farrar S, Yi D, Sutton M, Chalkley M, Sussex J, Scott A. Has payment by results affected the way that English hospitals provide care? difference-in-differences analysis. BMJ. 2009;339:b3047. doi:10.1136/bmj.b3047
  32. Verzulli R, Fiorentini G, Lippi Bruni M, Ugolini C. Price changes in regulated healthcare markets: do public hospitals respond and how? Health Econ. 2017;26(11):1429-1446. doi:10.1002/hec.3435
  33. Januleviciute J, Askildsen JE, Kaarboe O, Siciliani L, Sutton M. How do hospitals respond to price changes? evidence from Norway. Health Econ. 2016;25(5):620-636. doi:10.1002/hec.3179
  34. Vainieri M, Ferrè F, Giacomelli G, Nuti S. Explaining performance in health care: how and when top management competencies make the difference. Health Care Manage Rev. 2019;44(4):306-317. doi:10.1097/hmr.0000000000000164
  35. Kotter JP, Schlesinger LA. Choosing strategies for change. In: Asch D, Bowman C, eds. Readings in Strategic Management. London: Palgrave Macmillan; 1989:294-306. doi:10.1007/978-1-349-20317-8_21
  36. Fiondella C, Macchioni R, Maffei M, Spanò R. Successful changes in management accounting systems: a healthcare case study. Accounting Forum. 2016;40(3):186-204. doi:10.1016/j.accfor.2016.05.004
  37. Lehtonen T. DRG-based prospective pricing and case-mix accounting—exploring the mechanisms of successful implementation. Manag Account Res. 2007;18(3):367-395. doi:10.1016/j.mar.2006.12.002
  38. Wang V, Lee SY, Maciejewski ML. Inertia in health care organizations: a case study of peritoneal dialysis services. Health Care Manage Rev. 2015;40(3):203-213. doi:10.1097/hmr.0000000000000024
  39. Pink DH. Drive: The Surprising Truth About What Motivates Us. Penguin Publishing Group; 2011.
  40. Flodgren G, Eccles MP, Shepperd S, Scott A, Parmelli E, Beyer FR. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev. 2011(7):CD009255. doi:10.1002/14651858.cd009255
  41. Godager G, Wiesen D. Profit or patients’ health benefit? exploring the heterogeneity in physician altruism. J Health Econ. 2013;32(6):1105-1116.  doi:10.1016/j.jhealeco.2013.08.008
  42. Siciliani L. Paying for performance and motivation crowding out. Econ Lett. 2009;103(2):68-71. doi:10.1016/j.econlet.2009.01.022
  43. Spoor C, Munro J. Do budget-holding physicians respond to price? the case of fundholding in the UK. Health Serv Manage Res. 2003;16(4):261-267. doi:10.1258/095148403322488955
  44. Berenson RA, Rice T. Beyond measurement and reward: methods of motivating quality improvement and accountability. Health Serv Res. 2015;50 Suppl 2:2155-2186. doi:10.1111/1475-6773.12413
  45. Ellis RP, Miller MMK. Provider payment methods and incentives. In: Carrin G, Buse K, Heggenhougen K, Quah SR, eds. Health Systems Policy, Finance, and Organization. Amsterdam: Elsevier Academic Press; 2009:322-329.
  46. Quentin W, Scheller-Kreinsen D, Blümel M, Geissler A, Busse R. Hospital payment based on diagnosis-related groups differs in Europe and holds lessons for the United States. Health Aff (Millwood). 2013;32(4):713-723. doi:10.1377/hlthaff.2012.0876
International Journal of Health Policy and Management
Volume 10, Issue 5
May 2021
Pages 244-254

  • Received Date 28 November 2019
  • Revised Date 01 April 2020
  • Accepted Date 04 April 2020
  • First Published Date 01 May 2021
  • Published Date 01 May 2021